John G. Lenehan
London, ON N6A5W9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy.
Journal: Cancer cell
Published: September 01, 2025
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.
Journal: Nature medicine
Published: August 12, 2025
Analyzing the effect of neoadjuvant stereotactic ablative body radiotherapy on pancreatic tumor perfusion using computed tomography perfusion.
Journal: Frontiers in oncology
Published: August 01, 2025
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Journal: Nature medicine
Published: July 24, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial.
Journal: Journal for immunotherapy of cancer
Published: July 15, 2025
Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).
Journal: The Journal of molecular diagnostics : JMD
Published: May 28, 2025
Health Care Impact of Comprehensive Genomic Profiling of Solid Tumors in Patient Management Using POWER (Precision Oncology at Western University).
Journal: The Journal of molecular diagnostics : JMD
Published: May 28, 2025
An adjunct microbiome therapy to enhance immunotherapy efficacy in melanoma patients.
Journal: Genes and immunity
Published: November 23, 2023
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial.
Journal: Nature medicine
Published: February 09, 2023
Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma.
Journal: Current oncology (Toronto, Ont.)
Published: January 20, 2022
Last Updated: 09/26/2026